HUTCHMED (China) (HMDCF) Change in Acquisitions & Divestments (2018 - 2021)
HUTCHMED (China)'s (HMDCF) quarterly Change in Acquisitions & Divestments came in at $50.0 million in Q2 2021, down 73.95% year-over-year from $191.8 million in Q2 2020, and down 74.97% quarter-over-quarter from $199.5 million in Q1 2021.
Analysis
HUTCHMED (China) (HMDCF) Change in Acquisitions & Divestments (2018 - 2021) Analysis & Trends
HUTCHMED (China) (HMDCF) has reported Change in Acquisitions & Divestments for 4 consecutive years, with $50.0 million the latest figure, recorded in Q2 2021.
- On a quarterly basis, Change in Acquisitions & Divestments fell 73.95% year-over-year to $50.0 million in Q2 2021; TTM through Jun 2021 was $537.3 million, a 8.6% increase from a year earlier, with the FY2025 full-year figure at $2.1 billion, up 20.29% from the prior year.
- Change in Acquisitions & Divestments was $50.0 million for Q2 2021 at HUTCHMED (China), down from $199.5 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $273.0 million in Q1 2018 and troughed at $50.0 million in Q2 2021.
- A 4-year average of $174.7 million and a median of $195.7 million in 2020 frame the typical range for Change in Acquisitions & Divestments.
- The widest YoY moves for Change in Acquisitions & Divestments: up 107.84% in 2021, down 73.95% in 2021.
- Over 4 years, Change in Acquisitions & Divestments stood at $202.4 million in 2018, then tumbled by 70.4% to $59.9 million in 2019, then jumped by 220.0% to $191.8 million in 2020, then tumbled by 73.95% to $50.0 million in 2021.
- The last three Change in Acquisitions & Divestments figures came in at $50.0 million (Q2 2021), $199.5 million (Q1 2021), and $191.8 million (Q2 2020), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.37 Bn | 197.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.12 Bn | 177.94 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.11 Bn | 124.26 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.51 Bn | 74.52 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.69 Bn | 56.50 Bn | 1.37 Bn |
| 6 | Moderna | 54.62 Bn | 49.48 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.14 Bn | 30.84 Bn | 992.69 Mn |
| 8 | Biogen | 31.29 Bn | 30.01 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.09 Bn | 30.09 Bn | 1.16 Mn |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | 49.95 Mn |
| Mar 31, 2021 | 199.55 Mn |
| Jun 30, 2020 | 191.76 Mn |
| Mar 31, 2020 | 96.01 Mn |
| Dec 31, 2019 | 59.93 Mn |
| Sep 30, 2019 | 147.03 Mn |
| Jun 30, 2019 | 180.17 Mn |
| Mar 31, 2019 | 209.92 Mn |
| Dec 31, 2018 | 202.44 Mn |
| Sep 30, 2018 | 242.19 Mn |
| Jun 30, 2018 | 244.00 Mn |
| Mar 31, 2018 | 273.03 Mn |